US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist
  • 1.1850
  • -0.0050-0.42%
Close Apr 26 16:00 ET
9.39MMarket Cap-592P/E (TTM)

Akari Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akari Therapeutics Earnings Date

Currency: USD

Period

FY2023 Annual Report

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-2.04

+64.03%
Analyst Rating

No Data

Akari Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/Q40.000 / 0.000--
--2022/Q3-- / 0.000--
--2021/Q10.000 / 0.000--
--2020/Q40.000 / ----
--2020/Q30.000 / 0.000--
--2020/Q20.000 / 0.000--
--2020/Q10.000 / 0.000--
--2019/Q40.000 / 0.000--
--2019/Q30.000 / 0.000--
--2019/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2022/Q40.000 / 0.000--
--2022/Q3-- / 0.000--
--2021/Q10.000 / 0.000--
--2020/Q40.000 / ----
--2020/Q30.000 / 0.000--
--2020/Q20.000 / 0.000--
--2020/Q10.000 / 0.000--
--2019/Q40.000 / 0.000--
--2019/Q30.000 / 0.000--
--2019/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Akari Therapeutics Earnings Reports

  • Akari Therapeutics | 10-K: Annual report

    Mar 30 04:19

  • Akari Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 29, 2023 20:01

  • Akari Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 21, 2023 20:00

  • Akari Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 6, 2023 20:59

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg